In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for ...

The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

There is no cure for vitiligo, but there are a variety of innovative treatments that your doctor may prescribe once you've been diagnosed. It's a really exciting time to be treating vitiligo ...

Biotech startup Ahammune Biosciences has raised $5 million in Series A funding round led by pi Ventures. The round also ...

Ahammune Biosciences, a clinical-stage therapeutics company focused on developing new treatments for skin diseases, has ...

Vitiligo is a skin condition that’s little understood and it often takes a long time to diagnose, but now a new treatment could help to cure it. It currently affects around 70 million people around ...

Though INCY's performance in the year so far has been good, increasing competition for Jakafi is a concern. We advise ...